O
12.76
0.02 (0.16%)
| Previous Close | 12.74 |
| Open | 12.62 |
| Volume | 91,624 |
| Avg. Volume (3M) | 297,620 |
| Market Cap | 237,854,720 |
| Price / Earnings (TTM) | 1,276.00 |
| Price / Earnings (Forward) | 13.62 |
| Price / Sales | 2.11 |
| Price / Book | 1.87 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | -16.33% |
| Operating Margin (TTM) | -9.64% |
| Diluted EPS (TTM) | -0.840 |
| Quarterly Revenue Growth (YOY) | 11.40% |
| Total Debt/Equity (MRQ) | 28.21% |
| Current Ratio (MRQ) | 2.82 |
| Operating Cash Flow (TTM) | 6.63 M |
| Levered Free Cash Flow (TTM) | 9.20 M |
| Return on Assets (TTM) | -1.20% |
| Return on Equity (TTM) | -12.91% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | OptimizeRx Corporation | Bullish | Bullish |
AIStockmoo Score
0.6
| Analyst Consensus | 3.0 |
| Insider Activity | -2.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -0.5 |
| Average | 0.60 |
|
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 14.98% |
| % Held by Institutions | 64.55% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 24.00 (Citizens, 88.09%) | Buy |
| Median | 23.00 (80.25%) | |
| Low | 17.00 (Stephens & Co., 33.23%) | Hold |
| Average | 21.33 (67.16%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 16.17 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stephens & Co. | 17 Nov 2025 | 17.00 (33.23%) | Hold | 14.79 |
| Citizens | 07 Nov 2025 | 24.00 (88.09%) | Buy | 15.65 |
| JMP Securities | 10 Oct 2025 | 23.00 (80.25%) | Buy | 18.08 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BESCH DOUG | - | 13.13 | -4,660 | -59,816 |
| D'SILVA ANDREW J. | - | 13.51 | -703 | -9,498 |
| GRECO THERESA | - | 12.74 | -1,420 | -18,091 |
| MERRELL BRENDAN W. | - | 13.51 | -289 | -3,904 |
| ODENCE-FORD MARION | - | 13.13 | -5,204 | -67,187 |
| SILVESTRO STEPHEN L | - | 13.13 | -4,955 | -64,354 |
| STELMAKH EDWARD | - | 13.13 | -5,046 | -65,355 |
| Aggregate Net Quantity | -22,277 | |||
| Aggregate Net Value ($) | -288,204 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 13.16 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| STELMAKH EDWARD | Officer | 23 Dec 2025 | Disposed (-) | 3,658 | 12.74 | 46,603 |
| BESCH DOUG | Officer | 23 Dec 2025 | Disposed (-) | 4,079 | 12.74 | 51,966 |
| ODENCE-FORD MARION | Officer | 23 Dec 2025 | Disposed (-) | 4,051 | 12.74 | 51,610 |
| SILVESTRO STEPHEN L | Officer | 23 Dec 2025 | Automatic sell (-) | 3,361 | 12.74 | 42,819 |
| GRECO THERESA | Officer | 23 Dec 2025 | Disposed (-) | 1,420 | 12.74 | 18,091 |
| BESCH DOUG | Officer | 19 Dec 2025 | Disposed (-) | 581 | 13.51 | 7,849 |
| BESCH DOUG | Officer | 19 Dec 2025 | Option execute | 1,964 | - | - |
| D'SILVA ANDREW J. | Officer | 19 Dec 2025 | Disposed (-) | 703 | 13.51 | 9,498 |
| MERRELL BRENDAN W. | Officer | 19 Dec 2025 | Disposed (-) | 289 | 13.51 | 3,904 |
| ODENCE-FORD MARION | Officer | 19 Dec 2025 | Disposed (-) | 1,153 | 13.51 | 15,577 |
| ODENCE-FORD MARION | Officer | 19 Dec 2025 | Option execute | 3,928 | - | - |
| SILVESTRO STEPHEN L | Officer | 19 Dec 2025 | Disposed (-) | 1,594 | 13.51 | 21,535 |
| SILVESTRO STEPHEN L | Officer | 19 Dec 2025 | Option execute | 6,546 | - | - |
| STELMAKH EDWARD | Officer | 19 Dec 2025 | Sell (-) | 1,388 | 13.51 | 18,752 |
| STELMAKH EDWARD | Officer | 19 Dec 2025 | Option execute | 5,237 | - | - |
| Show more | ||||||
| Date | Type | Details |
|---|---|---|
| 17 Dec 2025 | Announcement | OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network |
| 06 Nov 2025 | Announcement | OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance |
| 20 Oct 2025 | Announcement | OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |